Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events

J Clin Epidemiol. 2008 Jun;61(6):561-71. doi: 10.1016/j.jclinepi.2007.08.003. Epub 2008 Feb 14.

Abstract

Objective: We sought to examine the validity of specific hospital discharge codes in identifying drug toxicity precipitating hospitalization, among elderly users of high-risk medications.

Study design and setting: We conducted a cross-sectional evaluation assessing the diagnostic test characteristics of International Classification of Diseases-9 External-Cause-of-Injury codes (E-codes) compared with a reference standard of medical record review. This study was nested within a prospective cohort of elders using warfarin, digoxin, or phenytoin as identified in the Pharmaceutical Assistance Contract for the Elderly benefit program.

Results: We identified 4,803 subjects contributing 11,409 person-years of exposure to at least one of three drug groups. Subjects experienced 8,756 hospitalizations, of which 304 were deemed, by expert review, to be a result of an adverse event of warfarin, digoxin, or phenytoin. The sensitivity, specificity, and positive (PPVs) and negative predictive values for drug-specific E-codes were warfarin--25.5%, 98.3%, 46.6%, and 95.7%; digoxin--84.0%, 99.1%, 56.8%, and 99.8%; and phenytoin--86.7%, 98.7%, 59.1%, and 99.7%.

Conclusions: E-codes for digoxin and phenytoin have a high sensitivity, but E-codes for all three medications have poor PPVs, a result that might produce misclassification in studies based solely on discharge coding. Investigators should confirm such rare events via medical record review.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adverse Drug Reaction Reporting Systems / standards*
  • Aged
  • Anti-Arrhythmia Agents / adverse effects
  • Anticoagulants / adverse effects
  • Anticonvulsants / adverse effects
  • Cross-Sectional Studies
  • Digoxin / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Forms and Records Control / standards
  • Hospitalization / statistics & numerical data
  • Humans
  • International Classification of Diseases
  • Medical Records / standards*
  • Patient Discharge
  • Pennsylvania
  • Phenytoin / adverse effects
  • Warfarin / adverse effects

Substances

  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Anticonvulsants
  • Warfarin
  • Phenytoin
  • Digoxin